Labcorp Holdings Inc. (LH) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Labcorp Holdings Inc. (LH:NYSE), powered by AI.

Current Price
$264.76
P/E Ratio
25.1
Market Cap
22.0B
Sector
Healthcare
What is the Labcorp Holdings Inc. stock price forecast?

Labcorp Holdings Inc. is currently trading at $264.76. View real-time AI analysis on Alpha Lenz.

What is Labcorp Holdings Inc. insider trading activity?

View the latest insider trading data for Labcorp Holdings Inc. on Alpha Lenz.

What is Labcorp Holdings Inc.'s P/E ratio?

Labcorp Holdings Inc.'s P/E ratio is 25.1.

Labcorp Holdings Inc.

NYSE · LH
$264.76-0.27(-0.10%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Labcorp Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Labcorp Holdings Inc. trades at a P/E of 25.1 (premium valuation) with solid ROE of 10.5%.

Ask for details

Company Overview

Labcorp Holdings Inc. operates as a company providing comprehensive laboratory services across a variety of health disciplines. As a leader in diagnostic testing, Labcorp offers an extensive range of clinical laboratory services, from routine blood tests to sophisticated genetic analyses. These services are critical for enabling healthcare providers to diagnose, manage, and prevent diseases effectively. Labcorp is significant in its role supporting hospitals, physicians, and researchers by providing the necessary tools for medical assessment and scientific inquiry. The company is also engaged in drug development and commercialization through its subsidiary, Covance, which plays a pivotal role in pharmaceutical and biotechnological research. Labcorp’s operations are crucial in sectors such as oncology, cardiology, endocrinology, and infectious diseases, impacting how these fields advance in terms of research and patient care. Headquartered in Burlington, North Carolina, Labcorp has established itself as a vital contributor to the healthcare infrastructure, advancing patient outcomes and pioneering medical innovation since its inception in 1978.

CEOMr. Adam H. Schechter
SectorHealthcare
IndustryDiagnostics & Research
Employees60,900

Company Statistics

FY 2025

Profile

$22.03BMarket Cap
$13.95BRevenue
0.00Shares Out
60,900Employees

Margins

28.76%Gross
15.26%EBITDA
10.87%Operating
7.94%Pre-Tax
6.29%Net

Valuation

25.13P/E
2.56P/B
1.58EV/Sales
13.17EV/EBITDA
18.27P/FCF

Growth (CAGR)

5.55%Rev 3Yr
-0.04%Rev 5Yr
-4.71%Op Inc 3Yr
-12.45%Op Inc 5Yr
-11.83%Net Inc 3Yr
-10.83%Net Inc 5Yr

Returns

4.77%ROA
10.51%ROE
7.24%ROIC

Financial Health

$532.30MCash & Cash Equivalents
$9.22BNet Debt
112.96%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Labcorp Holdings Inc. (ticker: LH) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 60,900 employees. Market cap is $22.0B.

The current price is $264.76 with a P/E ratio of 25.13x and P/B of 2.56x.

ROE is 10.51% and operating margin is 10.87%. Annual revenue is $14.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Labcorp Holdings Inc. (LH) Stock Forecast 2026 $264.76 — Price, Financials & Analyst Targets | Alpha Lenz